Figure 1.

Between group changes in immuno-oncology proteins with tesamorelin treatment. Volcano plot showing the Log₂ Fold Change (x-axis) and -(Log₁₀ P-value) (y-axis) for each protein in the immuno-oncology panel. Proteins shown in red and labeled had False Discovery Rate < 0.1. Abbreviations: ADGRG1, adhesion G-protein coupled receptor G1; ARG1, Arginase-1; CCL3, C-C motif chemokine 3; CCL4, C-C motif chemokine 4; CD8A, T-cell surface glycoprotein CD8 alpha chain; CRTAM, cytotoxic and regulatory T-cell molecule; CSF-1, Macrophage colony-stimulating factor 1; Gal-9, Galectin-9; GZMA, Granzyme A; HGF, Hepatocyte growth factor; IL8, Interleukin-8; IL10, Interleukin-10; MCP-4, C-C motif chemokine 13.